↓ Skip to main content

Management of Mycoplasma genitalium infections – can we hit a moving target?

Overview of attention for article published in BMC Infectious Diseases, August 2015
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (89th percentile)

Mentioned by

1 news outlet
6 tweeters
1 Facebook page
2 Wikipedia pages


92 Dimensions

Readers on

93 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Management of Mycoplasma genitalium infections – can we hit a moving target?
Published in
BMC Infectious Diseases, August 2015
DOI 10.1186/s12879-015-1041-6
Pubmed ID

Jørgen Skov Jensen, Catriona Bradshaw


Mycoplasma genitalium is an etiological agent of sexually transmitted infections, but due to its fastidious growth requirements, only a few M. genitalium strains are available for determination of the activity of currently used and new antimicrobial agents.Recent clinical trials have demonstrated that treatment with azithromycin has decreasing efficacy due to an increasing prevalence of macrolide resistance, which is likely to be attributed to the widespread use of 1 g single dose azithromycin. Second line treatment with moxifloxacin is similarly under pressure from emerging resistance. The era of single dose monotherapy for uncomplicated STIs such as M. genitalium and N. gonorrhoeae, while convenient for patients and physicians, has been associated with escalating resistance and treatment failure and is now drawing to a close. There is a critical need for trials of combinations of existing registered drugs and new antimicrobial compounds, implementation of diagnostic testing combined with molecular detection of resistance, and antimicrobial surveillance.

Twitter Demographics

The data shown below were collected from the profiles of 6 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 93 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 93 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 16 17%
Other 14 15%
Researcher 14 15%
Student > Ph. D. Student 12 13%
Student > Bachelor 7 8%
Other 14 15%
Unknown 16 17%
Readers by discipline Count As %
Medicine and Dentistry 29 31%
Biochemistry, Genetics and Molecular Biology 14 15%
Agricultural and Biological Sciences 11 12%
Immunology and Microbiology 9 10%
Nursing and Health Professions 7 8%
Other 6 6%
Unknown 17 18%

Attention Score in Context

This research output has an Altmetric Attention Score of 16. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 March 2019.
All research outputs
of 18,404,646 outputs
Outputs from BMC Infectious Diseases
of 6,441 outputs
Outputs of similar age
of 246,411 outputs
Outputs of similar age from BMC Infectious Diseases
of 1 outputs
Altmetric has tracked 18,404,646 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 6,441 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.2. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 246,411 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 89% of its contemporaries.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them